VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Cboe Global Markets, Inc. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Cboe Global Markets, Inc.
CBOE · Cboe BZX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Cboe Global Markets, Inc.'s moat claims, evidence, and risks.
View CBOE analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Cboe Global Markets, Inc. leads (76 / 100 vs 62 / 100 for GSK plc).
- Segment focus: Cboe Global Markets, Inc. has 5 segments (60.8% in Options); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Cboe Global Markets, Inc. has 8 moat types across 4 domains; GSK plc has 4 across 3.
Primary market context
Cboe Global Markets, Inc.
Options
U.S. listed options exchanges (multi-listed + proprietary index options)
United States
Broker-dealers, market makers, institutional investors, retail order-flow intermediaries
Exchange operator (SRO) + derivatives listing venue + market data provider
60.8%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
Cboe Global Markets, Inc. strengths
GSK plc strengths
Segment mix
Cboe Global Markets, Inc. segments
Full profile >Options
Oligopoly
North American Equities
Competitive
Europe and Asia Pacific
Oligopoly
Futures
Quasi-Monopoly
Global FX
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.